title: Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient.
abstract: We reported a 23 years old male with chronic hepatitis C virus infection, discontinued from pegylated interferon/ribavirin combination therapy due to a lack of early virological response. He has developed activation of occult hepatitis B virus that was successfully treated by a one year of lamivudine therapy.
authors.affiliation: Tropical Medicine Department, Faculty of Medicine, Zagazig University, Egypt. emara_20007@yahoo.com
authors.forename: Mohamed H
authors.initials: MH
authors.lastname: Emara
authors.forename: Mohamed I
authors.initials: MI
authors.lastname: Radwan
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D060085:Coinfection; D004359:Drug Therapy, Combination; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use; D019259:Lamivudine / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D019562:Viral Load; D014775:Virus Activation; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D019259:Lamivudine; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a
references.citation: J Med Virol. 2001 Mar;63(3):220-7
references.pmid: 11170061
references.citation: Intervirology. 2000;43(2):95-101
references.pmid: 10971127
references.citation: J Clin Virol. 2007 Jun;39(2):101-5
references.pmid: 17452002
references.citation: J Med Virol. 2006;78 Suppl 1:S59-65
references.pmid: 16622880
references.citation: J Virol. 1993 Oct;67(10):5823-32
references.pmid: 8396658
references.citation: J Hepatol. 2009 Feb;50(2):227-42
references.pmid: 19054588
references.citation: J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5
references.pmid: 14518718
references.citation: Hepatology. 1999 Mar;29(3):928-38
references.pmid: 10051500
references.citation: Gastroenterology. 1992 Oct;103(4):1322-7
references.pmid: 1327934
references.citation: J Hepatol. 2008 Oct;49(4):652-7
references.pmid: 18715666
references.citation: Virol J. 2010 Nov 17;7:324
references.pmid: 21083926
references.citation: N Engl J Med. 1999 Jul 1;341(1):22-6
references.pmid: 10387938
references.citation: Hepatology. 2001 Jul;34(1):194-203
references.pmid: 11431751